Study summary · 2022 · Evidence review

Interactive RPM: clinical benefits and uncertain hospital effects

Clinical endpoints improved in some pooled analyses, but hospital use and quality-of-life benefits were not established.

Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence

Original publication

Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis

Donato Giuseppe Leo; Benjamin J R Buckley; Mahin Chowdhury; Stephanie L Harrison; Masoud Isanejad; Gregory Y H Lip; David J Wright; Deirdre A Lane; TAILOR investigators

University of Liverpool and Liverpool Centre for Cardiovascular Science, United Kingdom

Journal of Medical Internet Research · Online: · Issue: November 2022

Journal version of record. · Full text consulted.

What was studied

Design
Evidence review
Population
People with chronic health conditions
Sample
96 studies; 58 entered meta-analyses
Intervention
Interactive telemonitoring
Comparator
Usual care
Follow-up
Varied by study
Review search cutoff
2021-02-05
Setting
Multiple countries

Methods

Systematic review of clinical outcomes and implementation, including randomized and nonrandomized designs; the 96 studies are not 96 randomized trials.

Findings

Mortality favored telemonitoring (RR 0.71, 95% CI 0.56–0.89). Hospitalization was inconclusive (RR 1.02, 95% CI 0.85–1.23); quality of life also showed no clear improvement.

Limitations

Blood-pressure and HbA1c analyses were highly heterogeneous. Few studies reported adherence or satisfaction. The hospitalization estimate does not demonstrate increased risk despite the authors' wording.

What this means for care delivery

Keep physiological, utilization and experience outcomes separate; positive findings in one domain cannot establish benefits in another.